# Jaguar Uranium Corp.: financial statements, quarterly

JAGU · NYSE · CIK 2039273 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jagu.md) · [Financials](/companies/jagu/financials.md) · [Filings](/companies/jagu/filings.md) · [Insiders](/companies/jagu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jagu/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Net income | $m | [(0.5)](/filings/0001213900-26-056589.md) | [(0.4)](/filings/0001213900-26-088331.md) | [(19.9)](/filings/0001213900-26-056589.md) | [(0.9)](/filings/0001213900-26-088331.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001213900-26-056589.md) | [(0.06)](/filings/0001213900-26-088331.md) | [(1.33)](/filings/0001213900-26-056589.md) | [(0.04)](/filings/0001213900-26-088331.md) |
| Basic EPS | $ per share | [(0.06)](/filings/0001213900-26-056589.md) | [(0.06)](/filings/0001213900-26-088331.md) | [(1.33)](/filings/0001213900-26-056589.md) | [(0.04)](/filings/0001213900-26-088331.md) |

- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.1](/filings/0001213900-26-035549.md) | not reported | not reported | [0.1](/filings/0001213900-26-088331.md) | [20.2](/filings/0001213900-26-056589.md) | [0.4](/filings/0001213900-26-088331.md) |
| Current assets | $m | not reported | [0.4](/filings/0001213900-26-035549.md) | not reported | not reported | [0.2](/filings/0001213900-26-088331.md) | [20.4](/filings/0001213900-26-056589.md) | [19.4](/filings/0001213900-26-088331.md) |
| Total assets | $m | not reported | [8.6](/filings/0001213900-26-035549.md) | not reported | not reported | [8.4](/filings/0001213900-26-088331.md) | [28.5](/filings/0001213900-26-056589.md) | [27.6](/filings/0001213900-26-088331.md) |
| Current liabilities | $m | not reported | [0.4](/filings/0001213900-26-035549.md) | not reported | not reported | [1.0](/filings/0001213900-26-088331.md) | [0.6](/filings/0001213900-26-056589.md) | [0.5](/filings/0001213900-26-088331.md) |
| Total liabilities | $m | not reported | [1.8](/filings/0001213900-26-035549.md) | not reported | not reported | [2.5](/filings/0001213900-26-088331.md) | [2.0](/filings/0001213900-26-056589.md) | [1.9](/filings/0001213900-26-088331.md) |
| Shareholders' equity | $m | [0.5](/filings/0001213900-26-035549.md) | [6.7](/filings/0001213900-26-088331.md) | [6.9](/filings/0001213900-26-056589.md) | [7.1](/filings/0001213900-26-088331.md) | [5.9](/filings/0001213900-26-088331.md) | [26.6](/filings/0001213900-26-056589.md) | [25.7](/filings/0001213900-26-088331.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(256)](/filings/0001213900-26-056589.md) | [(213) d](/filings/0001213900-26-088331.md) | [(2,602)](/filings/0001213900-26-056589.md) | [(1,243) d](/filings/0001213900-26-088331.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [8.6](/filings/0001213900-26-056589.md) | [7.1](/filings/0001213900-26-088331.md) | [14.9](/filings/0001213900-26-056589.md) | [20.2](/filings/0001213900-26-088331.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,193,777 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001213900-26-088331.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.